{"brief_title": "Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes", "brief_summary": "This trial is conducted in the United States of America (USA). The purpose of this study is to test whether Biphasic Insulin Aspart 70/30 twice a day with Metformin improves glycemic control vs. once daily Insulin Glargine with Metformin in subjects with Type 2 Diabetes who are inadequately controlled on basal insulin plus oral anti-diabetic therapy.", "condition": ["Diabetes", "Diabetes Mellitus, Type 2"], "intervention_type": ["Drug", "Drug"], "intervention_name": ["biphasic insulin aspart", "insulin glargine"], "criteria": "Inclusion Criteria: - Type 2 Diabetes", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "keyword": "Type 2 Diabetes", "mesh_term": ["Diabetes Mellitus", "Diabetes Mellitus, Type 2", "Insulin, Globin Zinc", "Insulin degludec, insulin aspart drug combination", "Insulin", "Biphasic Insulins", "Insulin Aspart", "Insulin, Long-Acting", "Insulin Glargine"], "id": "NCT00097877"}